Icosavax, Inc.

📍 Seattle, United States🗓 Founded 2018👥 11 employees
🌐 icosavax.com
Website LinkedIn
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Icosavax, Inc. founded?
Icosavax, Inc. was founded in 2018.
Where is Icosavax, Inc. based?
Icosavax, Inc. is headquartered in Seattle, United States.